NCT05817799View on ClinicalTrials.gov

Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

July 2, 2023

Study Completion Date

July 10, 2023

Conditions
Hemodialysis Complication
Interventions
DRUG

L-Carnitine 500Mg thrice daily

L-Carnitine 500mg oral thrice daily

DRUG

1g L-Carnitine IV three times a week

1g IV L-Carnitine three times a week

Trial Locations (1)

021

Jinnah Post Graduate Medical Center, Karachi

All Listed Sponsors
lead

Bahria University

OTHER

collaborator

Pakistan Navy Station Shifa Hospital

OTHER

collaborator

Jinnah Postgraduate Medical Centre

OTHER_GOV

collaborator

University of Karachi

OTHER